期刊
HUMAN MUTATION
卷 19, 期 4, 页码 -出版社
WILEY-BLACKWELL
DOI: 10.1002/humu.9025
关键词
osteopontin; SPP1; systemic lupus erythematosus; SLE; SNP; association
资金
- NIH [AI44127]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044127] Funding Source: NIH RePORTER
Osteopontin (SPP1) is a soluble ligand with pleomorphic immunologic activities including activation of macrophage chemotaxis, promotion of Th1 responses, and activation of B1 B cells. It has been implicated in the development of murine lupus and is overexpressed in humans with systemic lupus erythematosus (SLE). We examined a polymorphism of osteopontin for an association with lupus in humans in an effort to determine whether there is any evidence that a genetic predisposition to altered osteopontin expression might explain the overexpression seen in human SLE patients. A silent polymorphism (707C>T, rs1126616) of osteopontin was significantly associated with SLE. Additional associations with renal disease and opportunisitic infections were suggested. This is the first phenotypic association with a polymorphic variant of osteopontin. (C) 2002 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据